by Jordana Choucair | May 20, 2022 | Life Sciences
A group of pharmaceutical companies has partnered with global cancer organizations to create the Access to Oncology Medicines (ATOM) Coalition – an alliance aimed at getting more oncology medications to poorer countries. In addition to providing the drugs, the...
by Jordana Choucair | May 20, 2022 | Opioid/Substance Use Disorders
The U.S. Department of Health and Human Services (HHS) announced it will provide nearly $1.5 billion to states and territories to help address the opioid epidemic. The Substance Abuse and Mental Health Services Administration (SAMHSA) will administer the funding,...
by Jordana Choucair | May 20, 2022 | Payers
A federal judge struck down a controversial rule that requires drug companies to include copay assistance like coupons into Medicaid rebates. District Court Judge Carl Nichols said that because the rebate statute only refers to the best price made to the insurer and...
by Jordana Choucair | May 19, 2022 | Life Sciences
President Biden invoked the Defense Production Act to address the baby formula shortage. The act allows the government more control over industrial production during emergencies and will direct suppliers of formula ingredients to prioritize delivery to various...
by Jordana Choucair | May 19, 2022 | Payers
The Center on Budget and Policy Priorities released a report urging Medicaid managed care plans to prepare for “unprecedented coordination” with state officials to ensure beneficiaries continue to get care after the COVID-19 public health emergency (PHE) ends. Experts...
Recent Comments